Key Highlights

  • Preliminary Q2 2026 revenue projected above $90 million, versus $44.3 million a year earlier.
  • Growth attributed to a recovery in China and strength in Asia-Pacific and the Americas.
  • Company cited continued macroeconomic and geopolitical headwinds in the Middle East and other regions.
  • Shares closed down 9% at $26.44.

STAAR Surgical (NASDAQ: STAA) shares closed down 9% at $26.44 even as the company projected preliminary second-quarter 2026 revenue surpassing $90 million, more than double the $44.3 million reported in the same period a year earlier.

What Happened

Management attributed the revenue increase primarily to a recovery in China, along with sustained strength across the broader Asia-Pacific and Americas regions.

The company said it continues to navigate macroeconomic and geopolitical headwinds within the Middle East and other specific regional markets.

Market Reaction

STAAR Surgical, a mid-cap ophthalmic device maker, saw shares fall 9% to close at $26.44 on the day the preliminary revenue figures were disclosed.

The decline occurred despite preliminary revenue guidance representing more than a doubling of the prior-year quarter, with the company simultaneously flagging ongoing regional headwinds.

Outlook

The company said it continues to navigate macroeconomic and geopolitical headwinds in the Middle East and other specific regional markets, even as it reported recovery in China and continued strength in Asia-Pacific and the Americas.

What did STAAR Surgical report for Q2 2026?

The company projected preliminary revenue surpassing $90 million, up from $44.3 million in the same quarter a year earlier.

What drove STAAR Surgical's revenue growth?

Management attributed the increase primarily to a recovery in China and continued strength in the Asia-Pacific and Americas regions.

Why did STAAR Surgical shares fall despite the revenue increase?

Shares fell 9% to $26.44 even with the preliminary revenue growth, as the company also cited ongoing headwinds in the Middle East and other specific markets.